Research Article| Volume 48, ISSUE 2, P105-112, June 2023

Download started.


Dosimetric comparison of pencil beam scanning proton therapy with or without multi-leaf collimator versus volumetric-modulated arc therapy for treatment of malignant glioma


      This study aimed to examine the dosimetric effect of intensity-modulated proton therapy (IMPT) with a multi-leaf collimator (MLC) in treating malignant glioma. We compared the dose distribution of IMPT with or without MLC (IMPTMLC+ or IMPTMLC-, respectively) using pencil beam scanning and volumetric-modulated arc therapy (VMAT) in simultaneous integrated boost (SIB) plans for 16 patients with malignant gliomas. High- and low-risk target volumes were assessed using D2%, V90%, V95%, homogeneity index (HI), and conformity index (CI). Organs at risk (OARs) were evaluated using the average dose (Dmean) and D2%. Furthermore, the dose to the normal brain was evaluated using from V5Gy to V40Gy at 5 Gy intervals. There were no significant differences among all techniques regarding V90%, V95%, and CI for the targets. HI and D2% for IMPTMLC+ and IMPTMLC- were significantly superior to those for VMAT (p < 0.01). The Dmean and D2% of all OARs for IMPTMLC+ were equivalent or superior to those of other techniques. Regarding the normal brain, there was no significant difference in V40Gy among all techniques whereas V5Gy to V35Gy in IMPTMLC+ were significantly smaller than those in IMPTMLC- (with differences ranging from 0.45% to 4.80%, p < 0.05) and VMAT (with differences ranging from 6.85% to 57.94%, p < 0.01). IMPTMLC+ could reduce the dose to OARs, while maintaining target coverage compared to IMPTMLC- and VMAT in treating malignant glioma.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Medical Dosimetry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Ostrom Q.T.
        • Bauchet L.
        • Davis F.G.
        • et al.
        The epidemiology of glioma in adults: A state of the science review.
        Neuro. Oncol. 2014; 16: 896-913
        • Stupp R.
        • Mason W.P.
        • van den Bent M.J.
        • et al.
        Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
        N. Engl. J. Med. 2005; 352: 987-996
        • Sulman E.P.
        • Ismaila N.
        • Armstrong T.S.
        • et al.
        Radiation therapy for glioblastoma: American Society of Clinical Oncology Clinical Practice guideline endorsement of the American Society for Radiation Oncology guideline.
        J. Clin. Oncol. 2017; 35: 361-369
        • Bedford J.L.
        Treatment planning for volumetric modulated arc therapy.
        Med. Phys. 2009; 36: 5128-5138
        • Yoshio K.
        • Wakita A.
        • Mitsuhashi T.
        • et al.
        Simultaneous integrated boost volumetric modulated arc therapy for middle or lower esophageal cancer using elective nodal irradiation: Comparison with 3D conformal radiotherapy.
        Acta. Med. Okayama. 2019; 73: 247-254
        • Pollul G.
        • Bostel T.
        • Grossmann S.
        • et al.
        Pediatric craniospinal irradiation with a short partial-arc VMAT technique for medulloblastoma tumors in dosimetric comparison.
        Radiat. Oncol. 2020; 15: 1-10
        • Zhang Y.
        • Huang Y.
        • Ding S.
        • et al.
        A dosimetric and radiobiological evaluation of VMAT following mastectomy for patients with left-sided breast cancer.
        Radiat. Oncol. 2021; 16: 1-11
        • Celik E.
        • Baus W.
        • Baues C.
        • et al.
        Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer.
        Radiat. Oncol. 2020; 15: 120
        • Moreno A.C.
        • Frank S.J.
        • Garden A.S.
        • et al.
        Intensity modulated proton therapy (IMPT) – The future of IMRT for head and neck cancer.
        Oral Oncol. 2019; 88: 66-74
        • Tran A.
        • Zhang J.
        • Woods K.
        • Yu V.
        • et al.
        Treatment planning comparison of IMPT, VMAT and 4Π radiotherapy for prostate cases.
        Radiat. Oncol. 2017; 12: 1-9
        • Matsuura T.
        • Fujii Y.
        • Takao S.
        • et al.
        Development and evaluation of a short-range applicator for treating superficial moving tumors with respiratory-gated spot-scanning proton therapy using real-time image guidance.
        Phys. Med. Biol. 2016; 61: 1515-1531
        • Yasui K.
        • Toshito T.
        • Omachi C.
        • et al.
        A patient-specific aperture system with an energy absorber for spot scanning proton beams: Verification for clinical application.
        Med. Phys. 2015; 42: 6999-7010
        • Winterhalter C.
        • Lomax A.
        • Oxley D.
        • et al.
        A study of lateral fall-off (penumbra) optimisation for pencil beam scanning (PBS) proton therapy.
        Phys. Med. Biol. 2018; 63025022
        • Yasui K.
        • Toshito T.
        • Omachi C.
        • et al.
        Evaluation of dosimetric advantages of using patient-specific aperture system with intensity-modulated proton therapy for the shallow depth tumor.
        J. Appl. Clin. Med. Phys. 2018; 19: 132-137
        • Smith B.
        • Gelover E.
        • Moignier A.
        • et al.
        Technical note: A treatment plan comparison between dynamic collimation and a fixed aperture during spot scanning proton therapy for brain treatment.
        Med. Phys. 2016; 43: 4693-4699
        • Adeberg S.
        • Harrabi S.B.
        • Bougatf N.
        • et al.
        Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma.
        Strahlenther. Onkol. 2016; 192: 770-779
        • Eekers D.B.P.
        • Roelofs E.
        • Cubillos-Mesías M.
        • et al.
        Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial.
        Acta Oncol. 2019; 58: 57-65
        • Sugiyama S.
        • Katsui K.
        • Tominaga Y.
        • et al.
        Dose distribution of intensity-modulated proton therapy with and without a multi-leaf collimator for the treatment of maxillary sinus cancer: A comparative effectiveness study.
        Radiat. Oncol. 2019; 14: 209
        • Fukumitsu N.
        • Yamashita T.
        • Mima M.
        • et al.
        Dose distribution effects of spot-scanning proton beam therapy equipped with a multi-leaf collimator for pediatric brain tumors.
        Oncol. Lett. 2021; 22: 1-8
        • Niyazi M.
        • Brada M.
        • Chalmers A.J.
        • et al.
        ESTRO-ACROP guideline “target delineation of glioblastomas.
        Radiother. Oncol. 2016; 118: 35-42
        • Eekers D.B.
        • In 't Ven L.
        • Roelofs E.
        • et al.
        The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology.
        Radiother. Oncol. 2018; 128: 37-43
        • Scoccianti S.
        • Detti B.
        • Gadda D.
        • et al.
        Organs at risk in the brain and their dose-constraints in adults and in children: A radiation oncologist's guide for delineation in everyday practice.
        Radiother. Oncol. 2015; 114: 230-238
        • Marks L.B.
        • Yorke E.D.
        • Jackson A.
        • et al.
        Use of normal tissue complication probability (NTCP) models in the clinic.
        Int. J. Radiat. Oncol. Biol. Phys. 2010; 76: S10-S19
        • Paddick I.
        A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note.
        J. Neurosurg. 2000; 93: 219-222
        • Kanda Y.
        Investigation of the freely available easy-to-use software “EZR” for medical statistics.
        Bone Marrow Transplant. 2013; 48: 452-458
        • Adeberg S.
        • Harrabi S.B.
        • Bougatf N.
        • et al.
        Dosimetric comparison of proton radiation therapy, volumetric modulated arc therapy, and three-dimensional conformal radiotherapy based on intracranial tumor location.
        Cancers (Basel). 2018; 10: 401
        • Fan X.
        • Huang Y.
        • Xu P.
        • et al.
        Dosimetric analysis of radiation-induced brainstem necrosis for nasopharyngeal carcinoma treated with IMRT.
        BMC Cancer. 2022; 22: 1-8
        • Nguyen S.M.
        • Sison J.
        • Jones M.
        • et al.
        Lens dose-response prediction modeling and cataract incidence in patients with retinoblastoma after lens-sparing or whole-eye radiation therapy.
        Int. J. Radiat. Oncol. 2019; 103: 1143-1150
        • Pan C.C.
        • Eisbruch A.
        • Lee J.S.
        • et al.
        Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.
        Int. J. Radiat. Oncol. Biol. Phys. 2005; 61: 1393-1402
        • Eekers D.B.P.
        • In 't Ven L.
        • Deprez S.
        • et al.
        The posterior cerebellum, a new organ at risk?.
        Clin. Transl. Radiat. Oncol. 2018; 8: 22-26
        • Gan H.K.
        • Bernstein L.J.
        • Brown J.
        • et al.
        Cognitive functioning after radiotherapy or chemoradiotherapy for head-and-neck cancer.
        Int. J. Radiat. Oncol. Biol. Phys. 2011; 81: 126-134
        • Emami B.
        • Lyman J.
        • Brown A.
        • et al.
        Tolerance of normal tissue to therapeutic irradiation.
        Int. J. Radiat. Oncol. Biol. Phys. 1991; 21: 109-122
        • Curnes J.T.
        • Laster D.W.
        • Ball M.R.
        • et al.
        MRI of radiation injury to the brain.
        Am. J. Roentgenol. 1986; 147: 119-124
        • Moteabbed M.
        • Yock T.I.
        • Depauw N.
        • et al.
        Impact of spot size and beam-shaping devices on the treatment plan quality for pencil beam scanning proton therapy.
        Int. J. Radiat. Oncol. Biol. Phys. 2016; 95: 190-198